MXPA02012316A - Uso de taliporfina o su derivados en el tratamiento de padecimientos cardiacos y preparacion de la misma. - Google Patents

Uso de taliporfina o su derivados en el tratamiento de padecimientos cardiacos y preparacion de la misma.

Info

Publication number
MXPA02012316A
MXPA02012316A MXPA02012316A MXPA02012316A MXPA02012316A MX PA02012316 A MXPA02012316 A MX PA02012316A MX PA02012316 A MXPA02012316 A MX PA02012316A MX PA02012316 A MXPA02012316 A MX PA02012316A MX PA02012316 A MXPA02012316 A MX PA02012316A
Authority
MX
Mexico
Prior art keywords
thaliporphine
derivatives
treatment
preparation
same
Prior art date
Application number
MXPA02012316A
Other languages
English (en)
Inventor
Shoeisheng Lee
Original Assignee
Lotus Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/644,932 external-priority patent/US6313134B1/en
Application filed by Lotus Pharmaceutical Co Ltd filed Critical Lotus Pharmaceutical Co Ltd
Publication of MXPA02012316A publication Critical patent/MXPA02012316A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

La presente invencion describe taliporfina y sus derivados para el tratamiento y profilaxis de padecimientos cardiacos, que incluyen la arritmia cardiaca, isquemia miocardial o infartacion al miocardio, y la muerte repentina provocada por la arritmia cardiaca o infartacion miocardial aguda.
MXPA02012316A 2000-08-23 2001-02-28 Uso de taliporfina o su derivados en el tratamiento de padecimientos cardiacos y preparacion de la misma. MXPA02012316A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/644,932 US6313134B1 (en) 2000-05-04 2000-08-23 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same
PCT/CN2001/000304 WO2002016325A1 (en) 2000-08-23 2001-02-28 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same

Publications (1)

Publication Number Publication Date
MXPA02012316A true MXPA02012316A (es) 2005-04-19

Family

ID=24586946

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012316A MXPA02012316A (es) 2000-08-23 2001-02-28 Uso de taliporfina o su derivados en el tratamiento de padecimientos cardiacos y preparacion de la misma.

Country Status (19)

Country Link
EP (1) EP1311486B1 (es)
JP (1) JP2004506719A (es)
KR (1) KR100522008B1 (es)
CN (1) CN1176909C (es)
AT (1) ATE325099T1 (es)
AU (2) AU2001248226B2 (es)
BR (1) BR0111761A (es)
CA (1) CA2412170C (es)
CY (1) CY1105432T1 (es)
DE (1) DE60119336T2 (es)
DK (1) DK1311486T3 (es)
ES (1) ES2260209T3 (es)
HU (1) HUP0301971A3 (es)
IL (1) IL153205A (es)
MX (1) MXPA02012316A (es)
PT (1) PT1311486E (es)
RU (2) RU2350326C2 (es)
WO (1) WO2002016325A1 (es)
ZA (1) ZA200209965B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843963B1 (fr) * 2002-08-30 2004-10-22 Sederma Sa Nouvelles molecules derivees de la noraporphine
JP2006527699A (ja) * 2003-06-19 2006-12-07 美時化学製薬股▲ふん▼有限公司 アポルフィン、及び、ケトンアポルフィン化合物とその用途
US20140155609A9 (en) * 2010-11-24 2014-06-05 Dong-A St Co., Ltd. Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757335C3 (de) * 1977-12-22 1982-03-25 Gödecke AG, 1000 Berlin Verfahren zur O-Methylierung von Hydroxyaporphinen
DE3118521A1 (de) * 1981-05-09 1982-12-02 Gödecke AG, 1000 Berlin Dibenzo(de,g)chinolin-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkaeltungskrankheiten und allergien
JPS6416722A (en) * 1987-07-13 1989-01-20 Tsumura & Co Blood viscosity lowering agent

Also Published As

Publication number Publication date
CN1429212A (zh) 2003-07-09
KR100522008B1 (ko) 2005-10-18
RU2350326C2 (ru) 2009-03-27
CA2412170A1 (en) 2002-02-28
HUP0301971A2 (hu) 2003-09-29
DE60119336D1 (de) 2006-06-08
EP1311486A4 (en) 2004-03-31
HUP0301971A3 (en) 2007-09-28
BR0111761A (pt) 2003-06-24
IL153205A (en) 2007-06-17
AU2001248226B2 (en) 2004-07-08
CN1176909C (zh) 2004-11-24
EP1311486A1 (en) 2003-05-21
CA2412170C (en) 2007-01-02
KR20030009533A (ko) 2003-01-29
DE60119336T2 (de) 2007-05-10
ATE325099T1 (de) 2006-06-15
JP2004506719A (ja) 2004-03-04
RU2005140373A (ru) 2007-06-27
AU4822601A (en) 2002-03-04
RU2002133099A (ru) 2004-05-10
ZA200209965B (en) 2004-03-09
DK1311486T3 (da) 2006-09-04
CY1105432T1 (el) 2010-04-28
ES2260209T3 (es) 2006-11-01
IL153205A0 (en) 2003-07-06
PT1311486E (pt) 2006-09-29
EP1311486B1 (en) 2006-05-03
WO2002016325A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
MY140398A (en) 4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES
PL341364A1 (en) 4-hydroxyqinoline-3-carboxamides and hydrazides as antiviral agents
FI950255A (fi) Venyvä absorboiva rakenne
MXPA02007915A (es) Mediador de lipido activado por aspirina.
TW200510343A (en) Substituted dihydroquinazolines
WO2002024613A3 (en) Resorcinol derivatives
CA2318398A1 (en) Novel peptides having biological activity
AU5314900A (en) Compositions and methods for inhibiting cell death
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
MXPA02011039A (es) Combinaciones de productos activos fungicidas.
AP2001002274A0 (en) Rescorcinol derivatives.
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.
AU4822601A (en) Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same
IL161116A (en) Use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary arterial hypertension
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
EE200300506A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
UA94046C2 (ru) Пептиды, производные от тромбоспондина-1, и способы лечения
SI1276495T1 (sl) Uporaba rekombinantnega pljucnega surfaktanta za zgodnje zdravljenje akutnih pljucnih bolezni
WO2002028388A3 (en) Use of mek1 inhibitors as protective agents against damage due to ischemia
WO2002069972A3 (de) Triazolverbindungen und deren verwendung zur prophylaxe und therapie neurodegenerativer erkrankungen, hirntrauma und zerebraler ischämie
GR1004434B (el) Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων
IL172675A0 (en) Benzofuran derivatives and their use in the treatment of microbial infections
AU5868699A (en) Novel therapeutic use of compounds with beta-3-agonist activity
PL353952A1 (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one
TH36509EX (th) ตู้เสื้อผ้า 2 ประตู

Legal Events

Date Code Title Description
FG Grant or registration